These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1704988

  • 1. Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors.
    Limas CJ, Limas C.
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):945-51. PubMed ID: 1704988
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Subtype selective regulation of coupling of rat cardiac beta adrenoceptors to adenylate cyclase.
    Arnold IR, Mistry R, Barnett DB.
    Eur J Pharmacol; 1993 May 15; 245(3):285-9. PubMed ID: 8392940
    [Abstract] [Full Text] [Related]

  • 7. Cardiac beta-adrenoceptor regulation and the effects of partial agonism.
    Barnett DB, Lu XY.
    Am J Cardiol; 1991 May 06; 67(12):18C-19C. PubMed ID: 1673585
    [Abstract] [Full Text] [Related]

  • 8. Xamoterol activates beta 1- but not beta 2-adrenoceptors in mammalian myocardium: comparison of its affinity for beta 1- and beta 2-adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects.
    Lemoine H, Bilski A, Kaumann AJ.
    J Cardiovasc Pharmacol; 1989 Jan 06; 13(1):105-17. PubMed ID: 2468921
    [Abstract] [Full Text] [Related]

  • 9. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
    Haynes JM.
    Eur J Pharmacol; 2007 Sep 10; 570(1-3):18-26. PubMed ID: 17617401
    [Abstract] [Full Text] [Related]

  • 10. The in vitro pharmacology of xamoterol (ICI 118,587).
    Malta E, Mian MA, Raper C.
    Br J Pharmacol; 1985 May 10; 85(1):179-87. PubMed ID: 2862938
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intrinsic sympathomimetic activity of beta-adrenoceptor antagonists: down-regulation of cardiac beta 1- and beta 2-adrenoceptors.
    Reithmann C, Wieland F, Jakobs KH, Werdan K.
    Eur J Pharmacol; 1989 Nov 07; 170(3):243-55. PubMed ID: 2575997
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
    Galitzky J, Reverte M, Portillo M, Carpéné C, Lafontan M, Berlan M.
    Am J Physiol; 1993 Mar 07; 264(3 Pt 1):E403-12. PubMed ID: 8096365
    [Abstract] [Full Text] [Related]

  • 19. Rapid component I(Kr) of the guinea-pig cardiac delayed rectifier K(+) current is inhibited by beta(1)-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways.
    Karle CA, Zitron E, Zhang W, Kathöfer S, Schoels W, Kiehn J.
    Cardiovasc Res; 2002 Feb 01; 53(2):355-62. PubMed ID: 11827686
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.